Marsh & McLennan Companies, Inc. is projected to rise to $222.70 by 2027, a +25% move from its current price of $178.31. MRSH is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $175.59 | $178.32 | $181.10 | +0.01% |
| Jul 13 | $174.48 | $178.34 | $182.28 | +0.02% |
| Jul 14 | $173.64 | $178.35 | $183.19 | +0.02% |
| Jul 15 | $172.94 | $178.37 | $183.97 | +0.03% |
| Jul 16 | $172.32 | $178.38 | $184.65 | +0.04% |
| Jul 17 | $171.77 | $178.40 | $185.28 | +0.05% |
| Jul 18 | $171.26 | $178.41 | $185.86 | +0.06% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $171.26 | $178.41 | $185.86 | +0.06% |
| Week 2 | $168.48 | $178.51 | $189.14 | +0.11% |
| Week 3 | $166.40 | $178.61 | $191.72 | +0.17% |
| Week 4 | $164.68 | $178.71 | $193.94 | +0.23% |
| Week 5 | $163.19 | $178.81 | $195.93 | +0.28% |
| Week 6 | $161.87 | $178.92 | $197.76 | +0.34% |
| Week 7 | $160.66 | $179.02 | $199.47 | +0.40% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Marsh & McLennan Companies, Inc. is a professional services company in the Financial Services category that provides advisory services and insurance solutions to clients worldwide, focusing on risk, strategy, and people. The company operates through two segments: Risk and Insurance Services, and Consulting.
In Risk and Insurance Services, it offers risk management services, such as risk management, insurance broking, insurance program management, risk consulting, analytical modeling, and alternative risk financing solutions. It also provides insurance and reinsurance broking, strategic advisory and actuarial services, and analytics solutions for a broad client base that includes businesses, public entities, associations, professional services organizations, and private clients.
In Consulting, the firm provides health, wealth and career advice, solutions and products; and specialized management, strategic, economic, and brand consulting services. Marsh & McLennan Companies, Inc. was founded in 1871 and is headquartered in New York, New York.
Marsh & McLennan Companies, Inc. is currently priced at $172.14 per share, with a market capitalization of $82.94B and a market rank of 194.
The stock sits in the Financial Services universe with a broad global footprint across advisory and insurance-related services. The current price is complemented by a multi-year forecast that suggests a path from neutral near-term to a sustained bullish trajectory over the next several years.
Forecast data show 2026 with a neutral stance and an average price of $172.14, a broad range from $157.32 to $222.96, and an ROI of 0%. From 2027 onward, the outlook becomes increasingly bullish, with rising average prices and ROI through 2050, including a 2030 average of $303.78 and a 2050 average of $1,151.48. The forecast also presents higher potential maxima, culminating in $1,883.07 in 2050.
A major floor 16.0% below — a decisive break under it would weaken the trend.
The nearest floor, 11.8% below — buyers have tended to step in here.
Price is pressing into resistance (0.4% away) — a breakout level to watch.
A major ceiling 8.4% above — clearing it would confirm fresh momentum.
Key MRSH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MRSH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $177.82 | Buy | $177.42 | Buy |
| MA 10 | $174.22 | Buy | $174.71 | Buy |
| MA 20 | $169.54 | Buy | $171.24 | Buy |
| MA 50 | $165.98 | Buy | $169.04 | Buy |
| MA 100 | $170.96 | Buy | $171.66 | Buy |
| MA 200 | $178.65 | Sell | $179.57 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 62.71 | Neutral |
| Stoch RSI (14) | 86.36 | Sell |
| CCI (20) | 110.33 | Buy |
| Williams %R (14) | -3.91 | Info |
| MACD (12,26,9) | 1.38 | Buy |
| ROC (12) | 8.83 | Buy |
| Bollinger %B (20,2) | 0.86 | Neutral |
| Stochastic %K (14) | 96.09 | Sell |
| TRIX (15) | 0.20 | Buy |
| Awesome (5,34) | 11.19 | Buy |
| Ultimate (7,14,28) | 73.24 | Sell |
| Momentum (10) | 16.08 | Buy |
| Aroon Osc (25) | 92.00 | Buy |
| Hull MA (9) | 180.58 | Sell |
| ADX (14) | 16.19 | Neutral |
| ATR (14) | 2.51 | Info |
The 30-day technical picture is bullish overall. RSI14 sits at 60, and the price currently trades above the SMA50 of $165.42 but below the SMA200 of $179.22.
Support is seen at $157.32 and resistance at $172.14, with a 30-day price range of $155.30 to $190.80. This setup suggests constructive momentum near a key resistance level, with a clearly defined downside buffer and an upside path if buyers push above the resistance.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $157.32 | $178.31 | $231.36 | 0% | Neutral | |
| $182.39 | $222.70 | $284.31 | +25% | Bullish | |
| $214.44 | $266.76 | $349.76 | +50% | Bullish | |
| $225.32 | $284.62 | $381.12 | +60% | Bullish | |
| $244.65 | $313.21 | $426.95 | +76% | Bullish | |
| $249.84 | $323.76 | $448.32 | +82% | Bullish | |
| $253.87 | $332.70 | $467.24 | +87% | Bullish | |
| $292.12 | $386.85 | $550.33 | +117% | Bullish | |
| $336.14 | $449.57 | $647.19 | +152% | Bullish | |
| $360.39 | $486.57 | $708.25 | +173% | Bullish | |
| $479.43 | $675.12 | $1,029.83 | +279% | Bullish | |
| $794.75 | $1,200.28 | $1,962.57 | +573% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $157.32 | $178.31 | $214.13 | +0.00% |
| August 2026 | $154.52 | $180.90 | $216.38 | +1.45% |
| September 2026 | $152.71 | $179.63 | $216.53 | -0.70% |
| October 2026 | $156.55 | $184.91 | $224.36 | +2.94% |
| November 2026 | $160.32 | $190.01 | $231.82 | +2.76% |
| December 2026 | $158.68 | $188.67 | $231.36 | -0.71% |
Click any year to see its month-by-month MRSH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The MRSH price prediction for 2026 points to an average of $178.31 (low $157.32, high $231.36) — a potential gain of 0% on today's $178.31. A consolidation phase looks the most probable path here.
In 2027, MRSH is projected to trade between $182.39 and $284.31, averaging $222.70 — a potential gain of +25% from today's $178.31. That is up +25% on the projected 2026 average. Momentum favours further upside here.
Marsh & McLennan Companies, Inc.'s 2028 outlook centres on $266.76, within a $214.44 to $349.76 range. That is up +20% on the projected 2027 average. That marks a +50% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, MRSH could reach as high as $381.12, with a base case around $284.62 and support toward $225.32 — roughly +60% from $178.31. Momentum favours further upside here.
Expect MRSH to range from $244.65 to $426.95 through 2030. The $313.21 average target implies a +76% move from current prices. That is up +10% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The MRSH price prediction for 2031 points to an average of $323.76 (low $249.84, high $448.32) — a potential gain of +82% on today's $178.31. Momentum favours further upside here.
In 2032, MRSH is projected to trade between $253.87 and $467.24, averaging $332.70 — a potential gain of +87% from today's $178.31. That is up +3% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Marsh & McLennan Companies, Inc.'s 2033 outlook centres on $386.85, within a $292.12 to $550.33 range. That is up +16% on the projected 2032 average. That marks a +117% change versus current levels. Momentum favours further upside here.
By 2034, MRSH could reach as high as $647.19, with a base case around $449.57 and support toward $336.14 — roughly +152% from $178.31. Buyers look set to stay in control over this stretch.
Expect MRSH to range from $360.39 to $708.25 through 2035. The $486.57 average target implies a +173% move from current prices. That is up +8% on the projected 2034 average. Momentum favours further upside here.
The MRSH price prediction for 2040 points to an average of $675.12 (low $479.43, high $1,029.83) — a potential gain of +279% on today's $178.31. Buyers look set to stay in control over this stretch.
In 2050, MRSH is projected to trade between $794.75 and $1,962.57, averaging $1,200.28 — a potential gain of +573% from today's $178.31. That is up +78% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in MRSH today (≈ 5.60821 MRSH) could be worth
$6,731.4
+$5,731.4 (+573%) by 2050 · US Dollar
Based on the average projected MRSH price of $1,200.28 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MRSHwould be worth at today's price.
$1,000 invested in MRSH on Jul 10, 2025 (≈ 4.657445 MRSH) would be worth
$830.47
-$169.53 (-17.0%) today · 0.83× · US Dollar
Based on a MRSH entry price of $214.71 vs. today's $178.31.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $178.54 | $998.71 | -0.1% |
| 1 month ago | $167.15 | $1,066.77 | +6.7% |
| 3 months ago | $168.15 | $1,060.42 | +6.0% |
| 6 months ago | $185.63 | $960.57 | -3.9% |
| 1 year ago | $214.71 | $830.47 | -17.0% |
| All time (5.0y) ago | $141.83 | $1,257.21 | +25.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MRSH forecast.
Our base-case forecast reaches $360.00 around 2033.
Implied market cap at $360.00: $173.45B
The multi-year forecast points to a bullish trajectory with an upward revision of the average price across the years. The 2027 forecast shows an average price of $216.40, followed by continued strength in subsequent years, reaching an average of $303.78 in 2030 and extending to $1,151.48 by 2050.
Key mid- and long-term milestones include 2028 with an average of $258.46 and 2029 with an average of $274.03, while 2030 reaches $303.78 and 2031 reaches $312.02. The 2040 forecast climbs to an average of $650.76, and by 2050 the average is $1,151.48. Max values rise correspondingly, with 2033 at $537.36, 2034 at $624.82, 2035 at $678.03, 2040 at $992.87, and 2050 at $1,883.07.
Return-on-investment figures accompany these years, including 76.5% in 2030, 278% in 2040, and 568.9% in 2050, all with bullish sentiment.
These are estimates and not guaranteed.
Tap a question to reveal the answer.
Avg $303.78; min $237.21; max $414.27; ROI 76.5%; sentiment bullish.
Forecasts show neutral in 2026 with avg $172.14, then bullish from 2027 onward with rising averages and ROIs (e.g., 2027 avg $216.40, 2028 $258.46, 2040 $650.76, 2050 $1,151.48; 278% in 2040 and 568.9% in 2050).
2040 max $992.87 (below $1,000); 2050 max $1,883.07 (above $1,000).
Current price $172.14; market cap $82.94B.
2050 has the highest forecasted max price of $1,883.07.
Marsh & McLennan Companies, Inc. Community Discussion
0Share your Marsh & McLennan Companies, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.